Observational, Prospective, Cohort Study of Mpox Infection in Brazil (NETPOX)
The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow
| Condition(s) | Monkeypox, MPOX |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The study is a prospective cohort that evaluates the clinical and immune-metabolic variables that may be linked to the risk and severity of the infection or even hospitalization or death in patients infected with the Mpox virus in Brazil. The expectation is to include at least 80 patients over six months, with a follow-up of 90 days from inclusion, through contact via decentralized visits. |
| Who can participate | Inclusion Criteria: * Men and women aged ≥ 18 years with confirmed MPOX infection. (laboratory-confirmed monkeypox infection is defined as determined by PCR, culture, or antigen test obtained from a sample collected from blood, oropharynx, anal or skin lesion within 4 days of randomization) Exclusion Criteria: * Inability to provide informed consent; * Patient who, judging by the study team, does not have a condition for decentralized follow-up |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Hospital Israelita Albert Einstein |
| Locations | Belém, Pará, Brazil; São Paulo, São Paulo, Brazil; Rio de Janeiro, Brazil |
| Start date | 2024-07-16 |
| NCT ID | NCT05784038 |
| Official listing | https://clinicaltrials.gov/study/NCT05784038 |